scholarly journals Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: A retrospective study

2019 ◽  
Vol 90 (4) ◽  
pp. 608-616 ◽  
Author(s):  
Rosa Cervelli ◽  
Salvatore Mazzeo ◽  
Giuseppe Boni ◽  
Antonio Boccuzzi ◽  
Francesca Bianchi ◽  
...  
2020 ◽  
Vol 37 (1) ◽  
pp. 1082-1089
Author(s):  
Wei-Che Lin ◽  
Na-Ning Kan ◽  
Hsiu-Ling Chen ◽  
Sheng-Dean Luo ◽  
Yu-Cheng Tung ◽  
...  

2018 ◽  
Author(s):  
Andrea Palermo ◽  
Anda Mihaela Naciu ◽  
Mario Iozzino ◽  
Valerio Pasqualini ◽  
Carla Simeoni ◽  
...  

Diagnostics ◽  
2020 ◽  
Vol 10 (12) ◽  
pp. 1038
Author(s):  
Simone Agnes Schenke ◽  
Jan Wuestemann ◽  
Michael Zimny ◽  
Michael Christoph Kreissl

The Thyroid Imaging and Reporting System (TIRADS) allows a sonographic assessment of the malignancy risk of thyroid nodules (TNs). To date, there is a lack of systematic data about the change in ultrasound (US) features after therapeutic interventions. The aim of this study was to characterize the changes in autonomously functioning thyroid nodules (AFTNs) after radioiodine therapy (RIT) by using TIRADS. We retrospectively assessed data from 68 patients with AFTNs treated with RIT between 2016 and 2018 who had available first and second follow-up US imaging. Before RIT, 69.1% of the AFTNs were classified as low-risk TNs when applying Kwak TIRADS (EU-TIRADS 52.9%), 22.1% were intermediate-risk TNs (EU-TIRADS 19.1%), and 8.8% were high-risk TNs (EU-TIRADS 27.9%). Twelve months after RIT, 22.1% of the AFTNs showed features of high-risk TNs according to Kwak TIRADS (EU-TIRADS 45.6%). The proportion of intermediate TNs also increased to 36.8% (EU-TIRADS 29.4%), and 41.2% were low-risk TNs (EU-TIRADS 25%). A significant percentage of AFTNs presented with features suspicious for malignancy according to TIRADS before RIT, and this number increased significantly after therapy. Therefore, before thyroid US, thorough anamnesis regarding prior radioiodine treatment is necessary to prevent unneeded diagnostic procedures.


Thyroid ◽  
2015 ◽  
Vol 25 (1) ◽  
pp. 112-117 ◽  
Author(s):  
Jin Yong Sung ◽  
Jung Hwan Baek ◽  
So Lyung Jung ◽  
Ji-hoon Kim ◽  
Kyu Sun Kim ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Roberto Cesareo ◽  
Andrea Palermo ◽  
Valerio Pasqualini ◽  
Silvia Manfrini ◽  
Pierpaolo Trimboli ◽  
...  

2020 ◽  
Author(s):  
Alireza Arefzadeh ◽  
hossein ghanaati ◽  
Mahsa Alborzi Avankai ◽  
Alireza Abrishami ◽  
Hamidreza Niazkar ◽  
...  

Abstract Background: Thyroid nodules are a common clinical finding. Even though there are various accepted treatments for the benign thyroid nodules, there are alternative methods for managing these patients with fewer expenses and also minimum complications. This study aims to compare the volume decline of radiofrequency (RF) ablation and single-session ethanol ablation (EA) and the effects of levothyroxine therapy for benign thyroid nodule treatment.Materials: In this clinical trial, 90 patients with benign thyroid nodules in different centers in Tehran, Iran, from December 6, 2018, to December 6, 2019, were included. Patients who had met the inclusion criteria were selected and randomly allocated into three groups (each of 30) of a single session of radiofrequency ablation (Group 1), a single session of ethanol injection (Group 2), or a 6-month LT4 treatment (Group 3). Thyroid tests, including TSH, T4, T3, anti-TPO, T3RU, and serum Calcitonin level, were recorded at baseline and again at 1, 3, and six months. Nodule volume was also assessed through sonography at baseline and the other checkpoints.Results: The mean volume reduction after 6 months of intervention for ethanol injection group, radiofrequency ablation group, and LT4 treatment group were 72.2%, 83.4%, and 21.8%, respectively. There was a significant relationship between mean volume reduction and months (1, 3, and six) (P<0.001).Conclusions: Although radiofrequency ablation therapy is the best modality for managing benign thyroid nodules in our study, it is more expensive than the other modalities despite comparable therapeutic effects.


2009 ◽  
Vol 33 (9) ◽  
pp. 1971-1977 ◽  
Author(s):  
Jung Hwan Baek ◽  
Won-Jin Moon ◽  
Yoon Suk Kim ◽  
Jeong Hyun Lee ◽  
Ducky Lee

Sign in / Sign up

Export Citation Format

Share Document